Venus Remedies has informed that it enclosed a press release being issued by the Company titled ‘Venus Remedies extends Its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel’.
The above information is a part of company’s filings submitted to BSE.